RegASK is proud to participate in Pharma Japan 2025, Japan’s premier executive conference for the pharmaceutical industry, bringing together senior leaders from commercial, medical, R&D, regulatory, digital, and patient engagement functions.
This flagship event provides a dynamic platform to explore the future of pharma in Japan and the broader APAC region, with a strong focus on AI innovation, regulatory strategy, commercialization, and patient-centric transformation. Attendees can engage in interactive sessions, debates, and real-world case studies designed to deliver actionable insights and foster cross-functional collaboration.
🎤 Don’t Miss Our Speaking Session
Our Founder & CEO, Caroline Shleifer, will deliver a keynote on Agentic AI x Regulatory Intelligence: From Burden to Breakthrough, highlighting how AI agents are reshaping regulatory affairs and driving competitive advantage.
📍Meet Us in Tokyo
Join us on-site to learn how RegASK is empowering pharmaceutical companies with AI-driven regulatory intelligence. Our team will be available for in-person discussions:
Oliver Stein: Business Development Director
Natsumi Yamada: Customer Success Manager
Whether you’re looking to navigate Japan’s evolving regulations, streamline compliance workflows, or leverage AI for smarter regulatory strategies, we’d love to connect.
Let’s shape the future of regulatory affairs together at Pharma Japan 2025 in Tokyo!
Book a meeting